Roche Q3 Results - Q3 Top Pharma Company Earnings Reports

View Roche's Q3 Earnings Report

Highlights:

  • Group sales up 3.1 billion to 36.4 billion Swiss francs in first nine months, an increase of 11% in local currencies (9% in Swiss francs); both divisions grow significantly faster than their respective markets
  • Genentech integration progressing successfully
  • New Group leadership appointed

Check out Roche's current earnings estimates from CNN Money

Roche's Website: http://www.roche.com/

Roche Q3 Results - Q3 Top Pharma Company Earnings Reports
Read more on

Suggested Articles

One year after its landmark Reduce-It CV outcomes trial, Amarin has new data showing its Vascepa may help halt the progress of arterial plaque.

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

In its quest to become the dominant SGLT2 diabetes med for heart failure, Jardiance is touting DPP-4 inhibitor-topping data to support its case.